Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131617) titled 'An observational study on the impact of immune checkpoint inhibitors combined with CAPOX as firstline therapy on quality of life in patients with HER2negative advanced gastric cancer' on Sept. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Anhui Medical University
Condition:
Gastric cancer
Intervention:
PD-L1 monoclonal antibody group:None
PD-1/CTLA-4 bispecific antibody group:None
PD-1monoclonal antibody group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-11
Target Sample Size: PD-L1 monoclonal ...